HRP20110451T1 - Upotreba izotiocijanata kao sredstva protiv mieloma - Google Patents

Upotreba izotiocijanata kao sredstva protiv mieloma Download PDF

Info

Publication number
HRP20110451T1
HRP20110451T1 HR20110451T HRP20110451T HRP20110451T1 HR P20110451 T1 HRP20110451 T1 HR P20110451T1 HR 20110451 T HR20110451 T HR 20110451T HR P20110451 T HRP20110451 T HR P20110451T HR P20110451 T1 HRP20110451 T1 HR P20110451T1
Authority
HR
Croatia
Prior art keywords
myeloma
isothiocyanate derivatives
myeloma agents
agents
glucomoringin
Prior art date
Application number
HR20110451T
Other languages
English (en)
Croatian (hr)
Inventor
Morazzoni Paolo
Manzotti Carla
Fontana Gabriele
Riva Antonella
Iori Renato
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of HRP20110451T1 publication Critical patent/HRP20110451T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
HR20110451T 2008-01-18 2011-06-16 Upotreba izotiocijanata kao sredstva protiv mieloma HRP20110451T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100658A EP2080516B1 (en) 2008-01-18 2008-01-18 Use of isothiocyanate derivatives as anti-myeloma agents

Publications (1)

Publication Number Publication Date
HRP20110451T1 true HRP20110451T1 (hr) 2011-07-31

Family

ID=39247811

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110451T HRP20110451T1 (hr) 2008-01-18 2011-06-16 Upotreba izotiocijanata kao sredstva protiv mieloma

Country Status (17)

Country Link
US (1) US8772251B2 (ru)
EP (1) EP2080516B1 (ru)
JP (1) JP5386507B2 (ru)
KR (1) KR101523042B1 (ru)
CN (1) CN101918006B (ru)
AT (1) ATE511845T1 (ru)
AU (1) AU2008347390B2 (ru)
CA (1) CA2712258C (ru)
DK (1) DK2080516T3 (ru)
ES (1) ES2363385T3 (ru)
HR (1) HRP20110451T1 (ru)
IL (1) IL207011A (ru)
PL (1) PL2080516T3 (ru)
PT (1) PT2080516E (ru)
RU (1) RU2480217C2 (ru)
SI (1) SI2080516T1 (ru)
WO (1) WO2009089889A1 (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
RU2014116229A (ru) 2011-09-23 2015-10-27 Даблхил Гмбх Новые соединения изоцианата и изотиоцианата для лечения злокачественных новообразований
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
WO2014018874A1 (en) 2012-07-26 2014-01-30 The William M. Yarbrough Foundation Method for treating skin cancer
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
CN103262850B (zh) * 2013-01-16 2014-06-11 长沙理工大学 一种石蒜生长促进剂及其使用方法
EA026332B1 (ru) * 2013-03-14 2017-03-31 Общество с ограниченной ответственностью "Тиацен" Применение производных роданина для профилактики и/или лечения опухолевых заболеваний
US20160243176A1 (en) * 2013-11-01 2016-08-25 Rutgers, The State University Of New Jersey Extracts from plants of the moringaceae family and methods of making
EP3078371A1 (en) 2015-04-10 2016-10-12 INDENA S.p.A. Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain
CN107857781A (zh) * 2017-11-16 2018-03-30 云南农业大学 一种从辣木籽中制备4‑α‑L‑鼠李糖基‑异硫氰酸苄酯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100880498B1 (ko) * 2000-08-21 2009-01-28 제드 더블유. 파헤이 이소티오시아네이트에 의한 헬리코박터의 처리
US6988664B1 (en) * 2004-09-30 2006-01-24 Symbol Technologies, Inc. Removable cover for an electronic device
US20060127996A1 (en) * 2004-12-14 2006-06-15 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolate-containing plants and method of producing products with oil containing isothiocyanates extracted from glucosinolate-containing plants

Also Published As

Publication number Publication date
RU2480217C2 (ru) 2013-04-27
KR101523042B1 (ko) 2015-05-26
KR20100102660A (ko) 2010-09-24
ES2363385T3 (es) 2011-08-02
PT2080516E (pt) 2011-07-01
IL207011A0 (en) 2010-12-30
CN101918006B (zh) 2012-11-21
DK2080516T3 (da) 2011-07-11
RU2010129238A (ru) 2012-01-20
AU2008347390A1 (en) 2009-07-23
CA2712258A1 (en) 2009-07-23
CA2712258C (en) 2013-12-10
JP2011509955A (ja) 2011-03-31
WO2009089889A1 (en) 2009-07-23
AU2008347390B2 (en) 2014-03-13
EP2080516B1 (en) 2011-06-08
CN101918006A (zh) 2010-12-15
EP2080516A1 (en) 2009-07-22
PL2080516T3 (pl) 2011-12-30
IL207011A (en) 2014-04-30
US20110053870A1 (en) 2011-03-03
JP5386507B2 (ja) 2014-01-15
SI2080516T1 (sl) 2011-09-30
ATE511845T1 (de) 2011-06-15
US8772251B2 (en) 2014-07-08

Similar Documents

Publication Publication Date Title
HRP20110451T1 (hr) Upotreba izotiocijanata kao sredstva protiv mieloma
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
RS53301B (en) TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
NZ708593A (en) Novel pyrazole derivative
CO6410279A2 (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
CR10192A (es) Compuestos de amido y su uso como productos farmaceuticos
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
CO6741214A2 (es) Composiciones pesticidas y procesos relacionados
EA201400358A1 (ru) Замещенные n-[1-циано-2-(фенил)этил]-2-азабицикло[2.2.1]гептан-3-карбоксамидные ингибиторы катепсина с
MX2014002171A (es) Tratamientos de combinacion para hepatitis c.
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3
DK2040703T3 (da) Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
EP2215054B8 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
ATE505083T1 (de) Fungizide mischungen
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
CO6382113A2 (es) Compuestos quimicos
ATE474574T1 (de) Imidazoazephinonverbindungen
EA200801678A1 (ru) Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом
BR112013000296A2 (pt) agentes terapêuticos 976
GEP20125640B (en) Phenanthrenone compounds, compositions containing them and use thereof